Expanding Support for Mail-Based Naloxone Delivery

The opioid settlement funds provide a crucial opportunity to get increased state or municipal funding behind mail-based naloxone delivery. Through partnering with existing organizations that already have robust infrastructure in place and substantial experience in mail-based naloxone municipalities can scale efforts efficiently. The post Expanding Support for Mail-Based Naloxone Delivery appeared first on MedCity News.

Read More

Most of the Public Oppose Major Federal Cuts to Health Agencies and Programs and Say They Have Been Made “Recklessly”

As the Trump administration and Congress pursue broad cuts to federal health agencies and budgets, most of the public, including some Republicans, oppose deep budget and staffing cuts to federal health programs and agencies, a new KFF Health Tracking Poll finds. Across a range of questions, large majorities of Democrats and independents oppose the Trump…More

Read More

Tom Knight, Healthcare Diversion

Tom Knight is the Chairman of Healthcare Diversion, a nonprofit that is trying to educate about the topic of drug theft from facilities. This happens both because medical professionals are addicts (and victims themselves) and also because of organized crime and resale. The consequences are awful, with patients receiving water instead of analgesic drugs, getting…

Read More

Novartis Gets Phase 3-Ready Rare Kidney Disease Drug via $800M Regulus Acquisition

Regulus Therapeutics drug farabursen is a potential first-in-class treatment for a rare kidney disease whose only FDA-approved therapy introduces severe toxicity risks. Farabursen is joining a Novartis drug lineup spanning several therapies for rare renal disorders. The post Novartis Gets Phase 3-Ready Rare Kidney Disease Drug via $800M Regulus Acquisition appeared first on MedCity News.

Read More